-
Sector Analysis
Russia Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others
GlobalData’s “Russia Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Russia Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests The Russia Oncology Market report provides key information and data on - • Annualized market revenues (USD), volume (units) and average prices...
-
Sector Analysis
Peripheral Guidewires Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036
Peripheral Guidewires Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area. Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature. The aging population, the high prevalence of the disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates...
-
Thematic Analysis
FDI Trends in Africa (2025)
Overall, Africa’s share of global FDI remains small, however, investment opportunities across the continent are increasingly viewed as a growth frontier, presenting competitive long-term benefits. Notably, Africa continues to offer higher average profitability on FDI relative to other regions, despite ample structural deficiencies fueling a high-risk premium; this is supported by the fact that the largest 40 companies in Africa have annualized returns of 12.9% in the last year. GlobalData’s FDI Team expects FDI to diversifyaway from traditional, extractive industries...
-
Thematic Analysis
Impact of China on Medical Devices Industry: Strategic Intelligence
China is among the top 10 largest medical device markets worldwide and is regarded as one of the most promising. The estimated market value of medical devices in China was around $61.1 billion in 2024, accounting for 10.5% of the world total.
-
Thematic Analysis
Impact of US Tariffs on the Medical Devices Industry: Strategic Intelligence
US President Donald Trump’s administration has implemented widespread tariffs across various industries and countries. In response, many countries implemented reciprocal tariffs on the US. The tariffs could impact certain parts of the medical devices industry, especially those that are imported into the US.
-
Thematic Analysis
Point-of-Care Diagnostics: Strategic Intelligence
Point-of-care tests (POCTs) are medical tests performed at the time and place of patient care. Point-of-care (POC) diagnostics include blood glucose testing, rapid cardiac marker testing, and infectious disease testing. POC testing devices have enhanced the diagnostic capacity for several severe diseases and disorders, with the biggest selling point of the technology being the drastic reduction of turnaround time (TAT).
-
Thematic Analysis
Healthcare M&A Deals Q1 2025 - Top Themes: Strategic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2025 in the Healthcare Sector.
-
Thematic Analysis
Remote Patient Monitoring Devices: Strategic Intelligence
Remote patient monitoring (RPM) is the use of digital technologies and services to monitor, analyze, and capture the health data of patients and send this information to healthcare professionals for further evaluation. RPM devices can greatly improve the management of various chronic conditions. The primary goal of RPM devices is to accurately collect a wide range of health data for a patient, such as blood pressure, heart rate, vital signs, weight, and blood sugar levels. The patient’s health information is...
-
Thematic Analysis
Internet of Things (IoT) in Healthcare: Strategic Intelligence
The Internet of Things (IoT) describes the use of connected sensors and actuators to control and monitor the environment, the things that move within it, and the people that act within it. In healthcare, IoT devices are vital for remote patient monitoring (RPM) and decentralized clinical trials (DCTs). They also significantly contribute to predictive maintenance in supply chains and manufacturing.
-
Thematic Analysis
Regenerative Medicine in Medical - Strategic Intelligence
Regenerative medicine is a transformative area of healthcare focused on curing disease, eliminating cancer, and restoring damaged or aging tissues through gene therapy, cell therapy, and tissue repair. These therapies aim to restore biological function by correcting genetic defects, rebalancing cellular environments, or replacing damaged tissues.